Kappa immunoglobulin light chain gene rearrangement in a T-lineage chronic lymphocytic leukemia

C T Lutz1, M E Galles, J D Kemp

  • 1Department of Pathology, University of Iowa, Iowa City 52242.

Insights

This study found rearranged kappa immunoglobulin light chain genes in malignant T-lineage cells, challenging previous assumptions about B-cell specific gene rearrangement. Multiple tests are needed to accurately determine tumor cell lineage.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Traditionally, kappa immunoglobulin light chain gene rearrangement was exclusively associated with B-lymphoid cells.
  • Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, making exceptions rare and significant.

Purpose of the Study:

  • To investigate the lineage of malignant cells in a CLL patient exhibiting unusual genetic markers.
  • To determine if kappa immunoglobulin light chain genes can rearrange in T-lineage cells.

Main Methods:

  • Analysis of peripheral blood mononuclear cells from a CLL patient.
  • Utilized immunophenotypic analysis with T-lymphocyte and B-lymphocyte specific antibodies.
  • Conducted genotypic analysis of T-cell receptor beta-chain and immunoglobulin heavy chain genes.

Main Results:

  • The majority of malignant cells displayed T-lineage markers, including rearranged T-cell receptor beta-chain genes and germline immunoglobulin heavy chain genes.
  • Despite T-lineage markers, these cells also showed rearranged kappa immunoglobulin light chain genes.
  • This indicates the first conclusive evidence of rearranged kappa genes in malignant T-lineage cells.

Conclusions:

  • Gene rearrangement studies alone are insufficient for definitive tumor cell lineage determination.
  • Accurate lineage identification requires evaluating multiple immunophenotypic and genotypic parameters.
  • These findings highlight the importance of comprehensive analysis and offer models for studying lymphocyte receptor gene rearrangement in normal and malignant cells.